Randomized, Crossover Safety and Pharmacokinetics Study of PT010

Completed · Phase 1 · Has a placebo group

Conditions studied: COPD

In brief

Safety and Pharmacokinetics of Two Doses of PT010 in Healthy Adult Subjects of Japanese Descent Following a Single Dose and After Chronic Dosing for 7 Days.

Key facts

Study ID
NCT02197975
Run by
Pearl Therapeutics, Inc.
People needed
20
Starts
2014-08-01
Expected to finish
2014-10-01
Last updated by the study team
2014-10-28

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.